NeurAxis
Company

Last deal

$3.M

Amount

Post-IPO Equity

Stage

14.11.2023

Date

1

all rounds

$3.M

Total amount

General

About Company
Neuraxis is a medical technology company that develops non-drug medical devices to reduce functional abdominal pain in patients with IBS.

Industry

Sector :

Subsector :

Keywords :

Number of employees

Company Type

For Profit

Last funding type

Post-IPO Equity

IPO status

Private

Description

Neuraxis, formerly known as Innovative Health Solutions, specializes in developing neuromodulation therapies to address chronic and debilitating conditions in children. Their medical device system offers a non-narcotic alternative to acute and chronic pain, and they also provide a military field simulator. Founded in 2011 and based in Versailles, Indiana, Neuraxis aims to provide better patient outcomes by offering innovative solutions for pain management.
Contacts

Phone number

Social url